This phenomenon, termed “concentration-inducible ERα function”, involves serine 104/106/118-independent AF-1 transactivation and promotes breast tumor growth independently of estrogen, suggesting that ERα can drive transcription through mechanisms distinct from classical ligand-binding and phosphorylation-dependent pathways (182). This evidence concerns the gene ESR1 and breast neoplasm.